The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector easily access and use already available SIAPS resources, including tools, experiences, and results. The document is also intended to serve as a technical legacy for SIAPS to support knowledge exchange and sustainability of related work. The inventory is organized around the key program technical intervention areas as defined previously by the program. The document captures all key tools/approaches used by SIAPS (whether produced by SIAPS, a predecessor program, or a partner); selected country experiences in the form of technical reports or relevant materials; and other materials such as presentations, publications, technical briefs, and success stories that capture some of the results achieved by SIAPS.
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The SIAPS-developed AMR coalition-based strategy identifies educational institutions, such as UNAM; therapeutic committees (TCs); and key institutions involved in AMR, such as the National Institute of Pathology (NIP) as key players in the pre- and in-service training of health care professionals to enhance RMU and combat AMR. SIAPS collaborated with key institutions, including the MoHSS, Div:PhSs, UNAM-SOM, UNAM-SOP, NIP, and TCs in the Kunene and Karas regions, in activities to reduce hospital-acquired infections (HAIs); improve infection prevention and control (IPC); and promote RMU in Namibia.
Combating AMR with strong coalitions: Implementation experiences at the national and regional levels
Antimicrobial resistance (AMR) occurs when a microorganism becomes resistant to a drug that was originally effective for treating the infections it caused. It is one of the world’s most pressing global health threats and could erode progress made thus far in the treatment of HIV/AIDS, TB, malaria, and many other infectious diseases. Management Sciences for […]
SIAPS has been proactive in supporting Swaziland in various areas of the pharmaceutical sector, which has contributed to the containment of antimicrobial resistance. During the process of developing the National AMR Containment Strategic Plan, the stakeholders and the AMR committee have learned valuable lessons—in particular, the importance of the One Health approach, as well as the leadership and collaboration, financial and technical capacity required not only for the development of the strategic plan, but also for its implementation. Understanding the One Health approach at the early stages of the process is helpful in leadership and in collaboration with national and international stakeholders, and securing stakeholders’ technical and financial commitment, in addition to the government’s investment in the implementation of the strategic plan. SIAPS’ timely technical support played a key part in finalizing the National AMR Containment Strategic Plan.
Advancing the Antimicrobial Drug Quality Agenda through Coalition Building: Lessons from AMR Response
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS. Presented at a side event during the 2018 Prince Mahidol Awards Conference on the theme “Monitoring and Improving Medicines Quality through AMR National Action Plans”, organized by USP, USAID, the Thai Food and Drug Authority, and the Thai Department of Medical Sciences on January 29, 2018 in Bangkok, Thailand.
To learn more about SIAPS program activities worldwide, please read our annual report for program year 6.
Irrational medicine use and poor pharmaceutical management are widespread problems throughout all levels of Sierra Leone’s health system. Misuse, underuse, and overuse of medicines are particularly worrying because they contribute to the rise of antimicrobial resistance (AMR) and threaten the effective prevention and treatment of infections caused by bacteria, parasites, and viruses. Recognizing that coordinated […]
As part of World Antibiotic Awareness Week 2017, we present a Q&A with Mohan P. Joshi, MBBS, MSc, MD, SIAPS principal technical advisor. Dr. Joshi is responsible for providing technical guidance and support in the planning and implementation of rational medicine use and antimicrobial resistance (AMR)-related activities. Are there new AMR threats that are particularly worrying? […]
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS, at USAID in Arlington, VA on November 9 2017.
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats —one that could erode gains against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread. Immediate, cross-cutting, and multidisciplinary action is required to adequately address the multidimensional drivers of AMR. In the health sector, strengthening the systems through which health services and medicines are provided is a prerequisite to making progress against AMR. This technical brief discusses how SIAPS is working to address AMR through a health system strengthening approach with interventions spanning the global, regional, national, and local levels.
- The Use of Pharmaceutical Information for Decision Making in Namibia's National ART Program: Assessment Report
SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and […]
The Directorate of Drugs and Medical Supplies (DDMS) plays a key role in providing technical guidance and setting strategic direction […]
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]